140 related articles for article (PubMed ID: 27916547)
1. Role of several cytokines and adhesion molecules in the diagnosis and prediction of survival of hepatocellular carcinoma.
Iliaz R; Akyuz U; Tekin D; Serilmez M; Evirgen S; Cavus B; Soydinc H; Duranyildiz D; Karaca C; Demir K; Besisik F; Kaymakoglu S; Akyuz F
Arab J Gastroenterol; 2016 Dec; 17(4):164-167. PubMed ID: 27916547
[TBL] [Abstract][Full Text] [Related]
2. Assessment of prognostic and diagnostic value of some biomarkers in hepatocellular carcinoma.
Çavuş B; Akyuz F; İliaz R; Akyuz U; Duranyıldız D; Serilmez M; Tekin D; Evirgen S; Karaca Ç; Demir K; Beşışık F; Kaymakoğlu S
Exp Oncol; 2020 Sep; 42(3):208-214. PubMed ID: 32996733
[TBL] [Abstract][Full Text] [Related]
3. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
Schulze K; Gasch C; Staufer K; Nashan B; Lohse AW; Pantel K; Riethdorf S; Wege H
Int J Cancer; 2013 Nov; 133(9):2165-71. PubMed ID: 23616258
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the role of interleukin-6 in diagnosis of hepatocellular carcinoma.
El-Folly RF; El-Kabarity RH; Arafa NA
Egypt J Immunol; 2010; 17(2):11-22. PubMed ID: 23082483
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma.
Julich-Haertel H; Urban SK; Krawczyk M; Willms A; Jankowski K; Patkowski W; Kruk B; Krasnodębski M; Ligocka J; Schwab R; Richardsen I; Schaaf S; Klein A; Gehlert S; Sänger H; Casper M; Banales JM; Schuppan D; Milkiewicz P; Lammert F; Krawczyk M; Lukacs-Kornek V; Kornek M
J Hepatol; 2017 Aug; 67(2):282-292. PubMed ID: 28267620
[TBL] [Abstract][Full Text] [Related]
6. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
Yamashita T; Forgues M; Wang W; Kim JW; Ye Q; Jia H; Budhu A; Zanetti KA; Chen Y; Qin LX; Tang ZY; Wang XW
Cancer Res; 2008 Mar; 68(5):1451-61. PubMed ID: 18316609
[TBL] [Abstract][Full Text] [Related]
7. Contribution of biomarkers and imaging in the management of hepatocellular carcinoma.
Fartoux L; Decaens T
Clin Res Hepatol Gastroenterol; 2011 Jun; 35 Suppl 1():S21-30. PubMed ID: 21742297
[TBL] [Abstract][Full Text] [Related]
8. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
Yao M; Zhao J; Lu F
Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
[TBL] [Abstract][Full Text] [Related]
9. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
[TBL] [Abstract][Full Text] [Related]
10. Serum interleukin-18: does it have a role in the diagnosis of hepatitis C virus related hepatocellular carcinoma?
Mohran ZY; Ali-Eldin FA; Abdel Aal HA
Arab J Gastroenterol; 2011 Mar; 12(1):29-33. PubMed ID: 21429452
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic roles of serum vitronectin in hepatitis B-related hepatocellular carcinoma.
Yang XP; Zhou LX; Yang QJ; Liu L; Cai Y; Ma SL
Cancer Biomark; 2016 Sep; 17(3):271-279. PubMed ID: 27802203
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer.
Karabulut S; Tas F; Tastekin D; Karabulut M; Yasasever CT; Ciftci R; Güveli M; Fayda M; Vatansever S; Serilmez M; Disci R; Aydıner A
Tumour Biol; 2014 Sep; 35(9):8849-60. PubMed ID: 24891186
[TBL] [Abstract][Full Text] [Related]
13. High Epithelial Cell Adhesion Molecule-Positive Circulating Tumor Cell Count Predicts Poor Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization.
Shen J; Wang WS; Zhu XL; Ni CF
J Vasc Interv Radiol; 2018 Dec; 29(12):1678-1684. PubMed ID: 30392801
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of serum epithelial cell adhesion molecule (EPCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in patients with epithelial ovarian cancer.
Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
Tumour Biol; 2014 Apr; 35(4):3095-102. PubMed ID: 24307621
[TBL] [Abstract][Full Text] [Related]
15. Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma.
Tangkijvanich P; Thong-Ngam D; Mahachai V; Theamboonlers A; Poovorawan Y
World J Gastroenterol; 2007 Aug; 13(32):4345-9. PubMed ID: 17708609
[TBL] [Abstract][Full Text] [Related]
16. Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study.
Abdel-Razik A; Elhelaly R; Elzehery R; El-Diasty A; Abed S; Elhammady D; Tawfik A
Eur J Gastroenterol Hepatol; 2016 May; 28(5):599-605. PubMed ID: 26741637
[TBL] [Abstract][Full Text] [Related]
17. Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion.
Poté N; Cauchy F; Albuquerque M; Voitot H; Belghiti J; Castera L; Puy H; Bedossa P; Paradis V
J Hepatol; 2015 Apr; 62(4):848-54. PubMed ID: 25450201
[TBL] [Abstract][Full Text] [Related]
18. Serum level of soluble vascular cell adhesion molecule in patients with hepatocellular carcinoma and its association with severity of liver disease.
Diaz-Sanchez A; Matilla A; Nuñez O; Rincon D; Lorente R; Lo Iacono O; Merino B; Hernando A; Campos R; Clemente G; Bañares R
Ann Hepatol; 2013; 12(2):236-47. PubMed ID: 23396735
[TBL] [Abstract][Full Text] [Related]
19. IL-18 and interferon-gamma in HCV-related hepatocellular carcinoma: a model of interplay between immune status and cancer.
Perrella O; Cuomo O; Sbreglia C; Monaco A; Gnarini MR; Gentile B; Perrella M; Perrella A
J Biol Regul Homeost Agents; 2009; 23(4):251-8. PubMed ID: 20003764
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]